Chagas disease

Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusion Chagas disease: historical aspects, present situation, and perspectives

Case-control study of factors associated with chronic Chagas heart disease in patients over 50 years of age

Triatoma mexicana (Hemiptera: Reduviidae) in Guanajuato, Mexico: house infestation and seasonal variation

Experimental transmission of the parasitic flagellates Trypanosoma cruzi and Trypanosoma rangeli between triatomine bugs or mice and captive neotropical bats

A study of the scutellum in eight Chagas disease vector species from genus Triatoma (Hemiptera, Reduviidae) using optical and scanning electron microscopy

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagledogs

Infestation of rural houses by Triatoma infestans in the region of Los Llanos (La Rioja, Argentina)

Life cycle, feeding and defecation patterns of Rhodnius ecuadoriensis (Lent & León 1958) (Hemiptera: Reduviidae: Triatominae) under laboratory conditions

Delay in maturation of the submandibular gland in Chagas disease correlates with lower DNA synthesis

Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects

Pre-Columbian Chagas disease in Brazil: Trypanosoma cruzi I in the archaeological remains of a human in Peruaçu Valley, Minas Gerais, Brazil

Trypanocidal constituents in plants: 7. Mammea-type coumarins

Urban transmission of Chagas disease in Cochabamba, Bolivia

Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection

A potent trypanocidal component from the fungus Lentinus strigosus inhibits trypanothione reductase and modulates PBMC proliferation

Chromosome variability in the Chagas disease vector Rhodnius pallescens (Hemiptera, Reduviidae, Rhodniini)

Current status and perspectives of cell therapy in Chagas disease

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies

Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true

Chagas disease, adipose tissue and the metabolic syndrome

Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease

Do Archaea and bacteria co-infection have a role in the pathogenesis of chronic chagasic cardiopathy?

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research

All-around care for patients with Chagas disease: a challenge for the XXI century

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina

Morbidity and prognostic factors in chronic chagasic cardiopathy

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

Viability study of a multiplex diagnostic platform for Chagas disease

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Trypanosoma cruzi: ancestral genomes and population structure

Sylvatic triatominae: a new challenge in vector control transmission

Exploiting triatomine behaviour: alternative perspectives for their control

Wild Triatoma infestans, a potential threat that needs to be monitored

Biology, diversity and strategies for the monitoring and control of triatomines - Chagas disease vectors

Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

Paleoparasitology of Chagas disease: a review

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

Gap junction reduction in cardiomyocytes following transforming growth factor-β treatment and Trypanosoma cruzi infection

Morphological study of the eggs and nymphs of Triatoma dimidiata (Latreille, 1811) observed by light and scanning electron microscopy (Hemiptera: Reduviidae: Triatominae)

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi

Serological diagnosis of Chagas disease: evaluation and characterisation of a low cost antigen with high sensitivity and specificity

Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples

Epidermal growth factor receptors, testosterone levels and parotid gland changes in rats infected with Trypanosoma cruzi

Susceptibility of Triatoma infestans to deltamethrin in Rio Grande do Sul, Brazil

Present situation and new strategies for Chagas disease chemotherapy: a proposal

Inscrever-se em Chagas disease